The association of iron deficiency anemia and perioperative complications following revision total knee arthroplasty
Arthroplasty volume 4, Article number: 34 (2022)
Recent studies show an increase in the prevalence of iron deficiency anemia (IDA) worldwide and a concomitant rise in the number of revision total knee arthroplasty (RTKA). The literature evaluating the association between IDA and perioperative outcomes following RTKA are limited. Therefore, the purpose of this study was to determine whether IDA patients undergoing RTKA have higher rates of (1) in-hospital lengths of stay (LOS), (2) complications; and (3) costs.
Using International Classification of Disease, Ninth Revision (ICD-9) and Current Procedural Terminology (CPT), a retrospective query was performed from January 1st, 2005 to March 31st, 2014. The inclusion criteria consisted of those patients who have IDA undergoing RTKA. Study group patients were 1:5 ratio matched to a comparison cohort by age, sex, and various comorbidities: coronary artery disease, chronic obstructive pulmonary disease, diabetes mellitus, hyperlipidemia, hypertension, obesity, and tobacco use, yielding a total of 106,534 patients within the study (n = 17,784) and control (n = 88,750) cohorts. Outcomes assessed included: in-hospital LOS, costs of care, and medical complications. Multivariate Logistic regression analyses were used to calculate the odds-ratios (OR) and respective 95% confidence intervals (95%CI). Welch’s t-tests were used to compare in-hospital LOS and costs of care. Following Bonferroni-correction, a P-value less than 0.001 was considered statistically significant.
IDA patients undergoing RTKA were found to have significantly higher in-hospital LOS (4-days vs. 3-days, P < 0.0001). Additionally, IDA patients were found to have significantly higher odds (OR) of medical complications (OR: 5.29, P < 0.0001) such as: pneumonia (OR: 6.86, P < 0.0001), respiratory failures (OR: 5.95, P < 0.0001), myocardial infarctions (OR: 4.31, P < 0.0001) and other complications. Furthermore, IDA patients incurred significantly higher day of surgery ($16,976.01 vs. $14,515.81, P < 0.0001) and 90-day costs ($22,548.71 vs. $16,819.15, P < 0.0001).
The study demonstrated IDA patients undergoing RTKA have higher rates of in-hospital LOS, costs of care, and medical complications. Orthopedic surgeons and other healthcare professionals can use this information to adequately educate these patients of the potential complications following their procedure.
Studies have shown that preoperative anemia to be a prevalent comorbidity in patients undergoing primary elective total joint arthroplasty (TJA), with the frequency of the condition ranging from 21 to 35%, depending on the study being referenced [1,2,3]. One subset of anemic disorders is iron deficiency anemia (IDA), which is the leading cause of anemia worldwide, with one study citing that IDA contributed nearly 50% to all the anemic disorders . While the rate of IDA is low in the United States, approximately 10 million people are iron-deficient, with risk factors for the condition including blood loss, especially in the elderly, insufficient iron intake, and malabsorptive conditions, such as celiac disease . The societal and economic consequences of the condition are vast, leading to decreased work capacity and increased healthcare expenditures [4, 6]. Moreover, studies have demonstrated that IDA was associated with the development of adverse events following primary TJA [2, 7, 8].
In a retrospective study utilizing their own institution’s database, Viola et al. found that preoperative anemia following primary TJA was associated with higher rates of cardiovascular-related complications . Chamieh et al., utilizing an administrative database, showed that similar results that preoperative anemia in primary total knee arthroplasty (TKA) patients were associated with higher rates of pulmonary and renal-related complications . In a more recent investigation, Mathew et al. illustrated that IDA increased the frequency and odds of complications with the episode of care interval following primary TKA . While the aforementioned studies evaluated the anemia in the setting of primary TJA, currently, studies with a large sample size of patients utilizing multivariate analysis to determine the association of IDA in the setting of revision total knee arthroplasty (RTKA) have not been thoroughly elucidated. Understanding the relationship between IDA and RTKA will be essential to not only improving post-surgical patient care and potentially to mitigating the increased healthcare costs associated with this condition, but will serve to enhance the current literature on a comorbid condition with increasing prevalence worldwide [4, 9]. With the parallel rise of RTKA procedures being performed worldwide, studies evaluating the impact of IDA on RTKA outcomes are warranted .
As such, the aim of this study was to query a nationwide administrative claims database to identify IDA patients undergoing RTKA and to compare outcomes against a matched-cohort population. Specifically, this retrospective analysis examined whether IDA patients undergoing RTKA were correlated with higher rates of: (1) in-hospital lengths of stay (LOS); (2) healthcare expenditures; and (3) medical complications.
In order to investigate adverse outcomes of IDA patients undergoing RTKA procedures, a retrospective level III case-control query from January 1st, 2005 to March 31st, 2014 using the PearlDiver Patient Records Database (http://www.pearldiverinc.com, Colorado Springs, Colorado) platform was performed. The supercomputer contains deidentified patient information from a private payor and the Medicare administrative claims and consists of over 100 million patients. Due to a myriad of research variables available, the for-fee based platform has been used extensively by investigators. Information is queried using diagnostic and reimbursement billing terminology in the form of International Classification of Disease, the Ninth Revision (ICD-9) and Current Procedural Terminology (CPT). Since the current study does not contain patient information, the current investigation was deemed exempt from our Institutional Review Board (IRB) review process.
The database was initially queried by author S.H. to identify all patients who underwent revision TKA using ICD-9 procedural codes 84.57, 81.55, 00.80 to 00.84. The database was then queried for all patients with IDA using ICD-9 diagnostic code 280.1 to 280.9. These codes were chosen as they have been used in previous investigations to define RTKA procedures and diagnosis of IDA [8, 11]. To ensure that patients queried within the database were counted only once, the “FIRST_INSTANCE” command syntax was utilized to mitigate overestimation on the association of IDA on the outcomes assessed. RTKA patients who have IDA at the time of their revision procedure represented the study cohort, whereas patients without IDA served as the control cohort. Ratio matching at a 1:5 proportion was utilized to minimize the effects of confounding and increase the overall sample size of the study . Both cohorts were matched by the following matching parameters within the PearlDiver platform: age, sex, and the following medical comorbidities associated with IDA, including coronary artery disease, chronic obstructive pulmonary disease (COPD), diabetes mellitus, hyperlipidemia, hypertension, obesity, and tobacco use [13,14,15,16].
Primary variables to compare and assess between the study and matched-cohort population included: in-hospital lengths of stay (LOS), day of surgery and total global 90-day episode of care costs, and 90-day medical complications. Reimbursements were used as a substitute for costs of care, as it is a more accurate representation of what providers are paid from the insurance companies. Economic data were aggregated by the database tabulating all of the costs which patients in the cohorts may encounter on the day of their procedure to the time interval period of the investigator’s interest, in this case, 90-days following the index procedure. Information tabulated in the economic data can include, but not limited to: prescription refills, office visits, diagnostic tests pertaining to the index procedure, and other metrics [17,18,19]. Medical complications analyzed included: acute kidney injury, cerebrovascular accidents, deep vein thromboses, ileus, myocardial infarction, pneumonia, pulmonary emboli, respiratory failure, surgical site infection, urinary tract infection, and venous thromboemboli. Medical complications were defined using the ICD-9 codes found in the Supplementary Table 1.
Baseline demographics of the matched cohorts were analyzed by Pearson’s Chi-Square Analyses. Welch’s t-test was used to compare in-hospital LOS and healthcare expenditures between the cohorts. Multivariate Logistic regression analyses were used to determine the association of IDA with postoperative complications within the episode of care period. The regression model calculated odds-ratios (OR) and their respective 95% confidence intervals (95%CI) adjusted for age, sex, geographic region, and Elixhauser-Comorbidity Index (ECI). While the Charlson-Comorbidity Index (CCI) has historically been used for observational studies, the current investigation relied on ECI as an adjusting covariate as ECI has been shown not to be only superior to CCI, but also to contain nearly twice as many comorbid conditions, ensuring additional covariate adjustment within the data analyses [20, 21]. Due to the ease of finding statistical differences with large administrative claims databases, a Bonferroni-correction was performed to reduce the probability of a type I error, and an alpha-value less than 0.002 was utilized as the threshold to determine statistical significance in the study. This value was obtained by taking 0.05 and dividing it by the total number of dependent variables analyzed in the current investigation (n = 17), as done in previously published studies using administrative claims registries [22,23,24,25]. Statistical analyses were performed using R (R, Foundation for Computational Statistics, Vienna, Austria).
The query yielded a total of 106,534 patients in the study (17,784) and control (88,750) cohorts. Matching was successful as there was no statistical difference between the matched cohorts (Table 1).
In-hospital length of stay & healthcare expenditures
The study found that patients with IDA undergoing RTKA had significantly longer in-hospital LOS (4-days vs. 3-days, P < 0.0001), compared to patients without IDA undergoing the same procedure. Female IDA patients (4-days) had longer in-hospital LOS compared to their male counterparts (3-days). When analyzing healthcare expenditures between the two cohorts, IDA patients undergoing RTKA incurred significantly higher day of surgery ($16,976.01 vs. $14,515.81, P < 0.0001) costs compared to their non-IDA counterparts. Similarly, study group patients were found to have significantly higher 90-day episode of care costs ($22,548.71 vs. $16,819.15, P < 0.0001) compared to the matched-control population (Fig. 1).
IDA patients were also found to have significantly higher incidence and odds of medical complications (69.46% vs. 9.54%; OR: 5.29, 95%CI: 5.07 – 5.53, P < 0.0001) compared to their non-IDA counterparts. Specifically, the study found that IDA patients had significantly higher frequency and odds of developing acute kidney injuries (11.44% vs. 0.88%; OR: 7.06, 95%CI: 6.45 – 7.72, P < 0.0001), pneumonia (8.27% vs. 0.66%; OR: 6.86, 95%CI: 6.20 – 7.62, P < 0.0001), respiratory failures (7.18% vs. 0.61%; OR: 5.95, 95%CI: 5.33 – 6.64, P < 0.0001), ileus episodes (1.59% vs. 0.14%; OR: 5.62, 95%CI: 4.48 – 7.08, P < 0.0001), urinary tract infections (18.18% vs. 2.65%; OR: 5.21, 95%CI: 4.90 – 5.54, P < 0.0001), myocardial infarctions (1.95% vs. 0.22%; OR: 4.31, 95%CI: 3.55 – 5.24, P < 0.0001), cerebrovascular accidents (4.35% vs. 0.60%; OR: 4.03, 95%CI: 3.57 – 4.56, P < 0.0001), deep vein thromboses (4.07% vs. 0.89%; OR: 3.34, 95%CI: 2.99 – 3.73, P < 0.0001), surgical site infections (6.35% vs. 1.58%; OR: 3.22, 95%CI: 2.95 – 3.54, P < 0.0001), venous thromboemboli (4.61% vs. 1.02%; OR: 3.22, 95%CI: 2.90 – 3.57, P < 0.0001), and pulmonary emboli (1.47% vs. 0.28%; OR: 2.83, 95%CI: 2.33 – 3.43, P < 0.0001) (Table 2).
In the United States, there is an increase in the rates of primary TKA disproportionately affecting younger patients, that, when combined with the increased longevity of the population, will increase the demand for RTKA. Studies have conjectured that by 2030, there will be a 600% increase in the United States, amounting to over 250,000 procedures . Concurrently, IDA is an important comorbidity that is associated with poor surgical outcomes, with as many as 21% to 35% of patients undergoing elective primary and revision TKA having been diagnosed as being anemic . With the conjectured increase in the number of RTKA procedures worldwide within the next decade and high prevalence of IDA, the purpose of this investigation was to evaluate the association between IDA and patients undergoing RTKA. After adjusting for age, sex, and medical comorbidities, this study of over 106,000 patients demonstrated that IDA was associated with prolonged in-hospital LOS, in addition to higher rates of medical complications and healthcare expenditures following RTKA.
There are limitations associated with a retrospective database study. Due to the use of an administrative medical claims database, the validity of the study relied on the accuracy of the coding of the diagnoses and procedures, and it has been estimated that there are up to 3% of coding errors within the Medicare administrative claims database . In addition, the study assessed the association between an IDA diagnosis code and outcomes following RTKA. While comorbidities were controlled for, it is possible that IDA can be a marker for another disease process or influenced from another confounding variable from poor overall health. The claims database does not record laboratory values at either pre- or postoperative time points, which, however, can be an endpoint for future prospective studies. Additionally, due to the relatively wide time period, LOS data from earlier than 2014 might not be representative of the current time point, due to decreasing in-hospital LOS secondary to healthcare reform and the introduction of rapid recovery pathways . Furthermore, selection bias is commonly associated with case-control studies. While appropriate adjustments were made within the investigation by matching the study cohort to the comparison cohort by comorbidities which are commonly associated with IDA, selection bias might still be present within the investigation, which could potentially impact the results of the study. While the study used diagnostic codes which have been used in previously published arthroplasty studies, due to restrictions within the PearlDiver platform, the severity of IDA could not be assessed, as this could potentially impact the dependent variables measured in this study, and can potentially serve as the basis for future prospective investigations. Despite these limitations, there is value to the study as it utilized multivariate statistical analyses to determine the association between IDA and increased postoperative complications following RTKA, which can be used by orthopedists to guide patient care and promote further investigation into this topic.
The results of this study coincide with previously published investigations [7, 8, 27, 28]. This study found that IDA was associated with longer in-hospital LOS following RTKA compared to the control cohort. This was consistent with a single-institution, case-controlled study of 13,563 patients undergoing primary or revision TJA by Viola et al., which found that patients with preoperative anemia had increased LOS . In addition, a retrospective cohort study analyzing 2,394 patients undergoing elective primary TKA by Abdullah et al. found that preoperative anemia significantly increased LOS with increasing severity of the disease in patients with either mild anemia [adjusted OR (aOR) 1.71, P < 0.001] or moderate to severe anemia, (aOR 2.29, P < 0.001) . A retrospective study by Mathew et al. found that patients undergoing primary TKA with IDA had longer in-hospital LOS (4-days vs. 3-days, P < 0.0001) . However, limitations to the aforementioned studies include findings of the study not being generalizable to patients within the United States, not utilizing multivariate Logistic regression analyses to control for additional confounding variables, and not using a comprehensive list of diagnostic codes associated with IDA. In addition, while IDA remains the most common type of anemia, the studies mentioned did not distinguish IDA from other forms of anemia, such as anemia, from chronic diseases and other conditions, unlike the current study that only included IDA. In addition to the longer in-hospital course, the study showed IDA patients had significantly higher rates of morbidity compared to their counterparts undergoing RTKA.
IDA patients undergoing RTKA, compared to matched controls, were associated with significantly higher rates of pneumonia (OR: 6.86, P < 0.0001), respiratory failure (OR: 5.95, P < 0.0001), infections (OR: 3.22, P < 0.0001), and venous thromboemboli (OR: 3.22, P < 0.0001). While there is a lack of studies investigating pulmonary and venous thromboembolic complications following TJA in IDA patients, the study was consistent with other studies looking into postoperative complications following other surgical procedures. In a retrospective cohort analysis of 227,425 patients undergoing major non-cardiac surgery, Musallam et al. found that patients with anemia had higher rates of morbidities, including venous thromboemboli (OR: 1.57, P < 0.05) and respiratory complications (OR: 1.70, P < 0.05) . Another retrospective study of 2,064 patients in Africa by White et al. found that patients with severe anemia were more likely to be admitted to the ICU postoperatively from complications including myocardial infarction, renal failure, deep vein thrombosis and pneumonia (OR: 26.58, P < 0.001) . However, there are limitations to the above-mentioned studies as they included major non-cardiac surgeries not limited to orthopedic surgeries and did not further subdivide the study cohort to analyze any potential differences between surgery types. They also have limitations??? being generalizable to IDA patients in the United States and for not controlling for additional confounding variables through multivariate Logistic regression analysis.
Experimental evidence found that iron is essential for the normal development of the immune system . In iron deficiency, the decreased function of the immune system is mediated through impaired humoral immunity, phagocytic activity, oxidative burst, and decreased interleukin-6 (IL-6) levels which can account for the increased risk of infections . In addition, IDA is associated with an increased concentration of factor VIII, which is a risk factor for thrombosis [32, 33]. Anemia is also associated with a greater risk of symptomatic venous thromboembolism among acutely-ill medical patients such that patient risk can be stratified by hemoglobin levels . These hematopoietic derangements could potentially explain the higher rates of infections and thromboembolic complications which were observed in the study cohort. In addition to the higher rates of complications noted in the study, IDA patients undergoing RTKA were found to have higher costs of day of surgery and EOC compared to matched controls.
The study showed IDA patients incurred significantly higher day of surgery ($16,976.01 vs. $14,515.81) and 90-day EOC costs ($22,548.71 vs. $16,819.15) when compared to patients without IDA. This was consistent with another retrospective study that reported a significant increase of $15,869 in 90-day charges for patients with concomitant anemia undergoing primary joint arthroplasty . One possible explanation is that the IDA patients had significantly higher rates of medical complications following RTKA, so they incurred additional costs to treat the complications. Additional in-hospital estimated costs associated with acute renal failure treatment in the United States range from $7,469 to $33,161, depending on the severity of the illness . The estimated cost to treat pneumonia ranges from $1,126.9 for emergency department/urgent care visits to $10,962.50 for hospitalizations . The cost range of surgical site infections depends on the severity and location but averages to an additional cost of $5,155 . The additional medical complications and their respective treatments could account for differences in cost observed.
Reducing the incidence of medical complications can have a crucial impact on reducing the associated healthcare costs. A recent meta-analysis has found that a multidisciplinary patient blood management (PBM) program can reduce perioperative complication rates and be effective in improving clinical outcomes in patients with IDA . The first pillar of a PBM program is to optimize erythropoiesis by treating iron deficiency . Monitoring and correcting a patient’s iron levels can be essential to improving anemia management prior to surgery . Oral iron may be preoperatively given for mild-to-moderate anemia if there is sufficient time (6 to 8 weeks) and adequate tolerance to oral preparations . Intravenous iron should be used in cases of moderate-to-severe IDA, short time to surgery, and for postoperative anemia management . In a meta-analysis of 17 studies with 235,779 surgical patients by Althoff et al., the implementation of a PBM program significantly reduced transfusion rates by 39% (P < 0.00001), hospital length of stay (P < 0.00001), total number of complications (P < 0.00001), and mortality rate (P = 0.02) . Using a PBM program to manage a patients’ anemia can, in turn, reduce the overall costs following surgery.
This investigation found patients who had IDA undergoing RTKA had significant increase in LOS, healthcare costs, and frequency of adverse events within 90-days following RTKA. Future studies should aim at comparing the severity and duration of IDA on outcomes following the procedure, as this could potentially impact outcomes. There are currently no specific guidelines on how to manage preoperative anemia prior to RTKA, which could potentially lower medical complications and costs. The study is useful as it can be used by orthopedic surgeons and other healthcare professionals to adequately educate these patients of the potential complications following their procedure.
Availability of data and materials
Revision Total Knee Arthroplasty
Iron Deficiency Anemia
95% Confidence Interval
International Classification of Disease, Ninth Revision
Total Joint Arthroplasty
Total Knee Arthroplasty
Current Procedural Terminology
Institutional Review Board
Chronic Obstructive Pulmonary Disease
In-hospital lengths of stay
Spahn DR. Anemia and patient blood management in hip and knee surgery. Anesthesiology. 2010;113:482–95. https://doi.org/10.1097/ALN.0b013e3181e08e97.
Chamieh JS, Tamim HM, Masrouha KZ, Saghieh SS, Al-Taki MM. The association of anemia and its severity with cardiac outcomes and mortality after total knee arthroplasty in noncardiac patients. J Arthroplasty. 2016;31:766–70. https://doi.org/10.1016/j.arth.2015.10.035.
Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012;470:2695–701. https://doi.org/10.1007/s11999-012-2435-z.
Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of iron deficiency anemia. Gastroenterol Hepatol (N Y). 2015;11:241–50.
Miller JL. iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med. 2013;3:a011866–a011866. https://doi.org/10.1101/cshperspect.a011866.
Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131:676S–690S. https://doi.org/10.1093/jn/131.2.676S.
Viola J, Gomez MM, Restrepo C, Maltenfort MG, Parvizi J. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplasty. 2015;30:846–8. https://doi.org/10.1016/j.arth.2014.12.026.
Mathew KK, Vakharia RM, Salem HS, Sodhi N, Anis HK, Roche MW, et al. is iron deficiency anemia a risk factor for poorer outcomes in primary total knee arthroplasty? J Arthroplasty. 2020;35:1252–6. https://doi.org/10.1016/j.arth.2020.01.021.
Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull. 2003;24:S99–103. https://doi.org/10.1177/15648265030244S206.
Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop. 2011;35:1783–9. https://doi.org/10.1007/s00264-011-1235-5.
Lieber AM, Kirchner GJ, Kerbel YE, Moretti VM, Vakil JJ, Brahmabhatt S. Socioeconomic status is associated with risk of above-knee amputation after periprosthetic joint infection of the knee. Clin Orthop Relat Res. 2019;477:1531–6. https://doi.org/10.1097/CORR.0000000000000634.
Brazauskas R, Logan BR. Observational studies: matching or regression? Biol Blood Marrow Transplant. 2016;22:557–63. https://doi.org/10.1016/j.bbmt.2015.12.005.
Gandhi SJ, Hagans I, Nathan K, Hunter K, Roy S. Prevalence, comorbidity and investigation of anemia in the primary care office. J Clin Med Res. 2017;9:970–80. https://doi.org/10.14740/jocmr3221w.
Aigner E, Feldman A, Datz C. Obesity as an emerging risk factor for iron deficiency. Nutrients. 2014;6:3587–600. https://doi.org/10.3390/nu6093587.
Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med. 2014;14:24. https://doi.org/10.1186/1471-2466-14-24.
Soliman AT, De Sanctis V, Yassin M, Soliman N. Iron deficiency anemia and glucose metabolism. Acta Biomed. 2017;88:112–8. https://doi.org/10.23750/abm.v88i1.6049.
Martin CT, D’Oro A, Buser Z, Youssef JA, Park J-B, Meisel H-J, et al. Trends and costs of anterior cervical discectomy and fusion: a comparison of inpatient and outpatient procedures. Iowa Orthop J. 2018;38:167–76.
Cancienne JM, Patel KJ, Browne JA, Werner BC. Narcotic use and total knee arthroplasty. J Arthroplasty. 2018;33:113–8. https://doi.org/10.1016/j.arth.2017.08.006.
Vakharia RM, Sodhi N, Anis HK, Ehiorobo JO, Mont MA, Roche MW. Patients who have cannabis use disorder have higher rates of venous thromboemboli, readmission rates, and costs following primary total knee arthroplasty. J Arthroplasty. 2020;35:997–1002. https://doi.org/10.1016/j.arth.2019.11.035.
Menendez ME, Neuhaus V, van Dijk NC, Ring D. The elixhauser comorbidity method outperforms the charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472:2878–86. https://doi.org/10.1007/s11999-014-3686-7.
Maron SZ, Neifert SN, Ranson WA, Nistal DA, Rothrock RJ, Cooke P, et al. Elixhauser comorbidity measure is superior to charlson comorbidity index in-predicting hospital complications following elective posterior cervical decompression and fusion. World Neurosurg. 2020;138:e26–34. https://doi.org/10.1016/j.wneu.2020.01.141.
Sarpong NO, Boddapati V, Herndon CL, Shah RP, Cooper HJ, Geller JA. Trends in length of stay and 30-day complications after total knee arthroplasty: an analysis from 2006 to 2016. J Arthroplasty. 2019;34:1575–80. https://doi.org/10.1016/j.arth.2019.04.027.
Grosso MJ, Neuwirth AL, Boddapati V, Shah RP, Cooper HJ, Geller JA. Decreasing length of hospital stay and postoperative complications after primary total hip arthroplasty: a decade analysis from 2006 to 2016. J Arthroplasty. 2019;34:422–5. https://doi.org/10.1016/j.arth.2018.11.005.
Vakharia RM, Mannino A, Salem HS, Roche MW, Wong CHJ, Mont MA. The association between cannabis use disorder and the outcome following primary total hip arthroplasty. Bone Joint J. 2021;103-B(7 Supple B):111–5. https://doi.org/10.1302/0301-620X.103B7.BJJ-2020-2424.R1.
Haynes MS, Alder KD, Bellamkonda K, Kuzomunhu L, Grauer JN. Incidence, predictors, and timing of post-operative stroke following elective total hip arthroplasty and total knee arthroplasty. PLoS ONE. 2020;15:e0239239. https://doi.org/10.1371/journal.pone.0239239.
Frassanito L, Vergari A, Nestorini R, Cerulli G, Placella G, Pace V, et al. Enhanced recovery after surgery (ERAS) in hip and knee replacement surgery: description of a multidisciplinary program to improve management of the patients undergoing major orthopedic surgery. Musculoskelet Surg. 2020;104:87–92. https://doi.org/10.1007/s12306-019-00603-4.
Abdullah HR, Sim YE, Hao Y, Lin GY, Liew GHC, Lamoureux EL, et al. Association between preoperative anaemia with length of hospital stay among patients undergoing primary total knee arthroplasty in Singapore: a single-centre retrospective study. BMJ Open. 2017;7:e016403. https://doi.org/10.1136/bmjopen-2017-016403.
Schroer WC, Diesfeld PJ, LeMarr AR, Morton DJ, Reedy ME. Modifiable risk factors in primary joint arthroplasty increase 90-day cost of care. J Arthroplasty. 2018;33:2740–4. https://doi.org/10.1016/j.arth.2018.04.018.
Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396–407. https://doi.org/10.1016/S0140-6736(11)61381-0.
White MC, Longstaff L, Lai PS. Effect of pre-operative anaemia on post-operative complications in low-resource settings. World J Surg. 2017;41:644–9. https://doi.org/10.1007/s00268-016-3785-6.
Hassan TH, Badr MA, Karam NA, Zkaria M, El Saadany HF, Abdel Rahman DM, et al. Impact of iron deficiency anemia on the function of the immune system in children. Medicine (Baltimore). 2016;95:e5395. https://doi.org/10.1097/MD.0000000000005395.
Coutinho JM, Zuurbier SM, Gaartman AE, Dikstaal AA, Stam J, Middeldorp S, et al. association between anemia and cerebral venous thrombosis. Stroke. 2015;46:2735–40. https://doi.org/10.1161/STROKEAHA.115.009843.
Livesey JA, Manning RA, Meek JH, Jackson JE, Kulinskaya E, Laffan MA, et al. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia. Thorax. 2012;67:328–33. https://doi.org/10.1136/thoraxjnl-2011-201076.
Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, Younes A, et al. Association of anemia with Venous Thromboembolism in acutely ill hospitalized patients: an APEX trial substudy. Am J Med. 2018;131:972.e1–972.e7. https://doi.org/10.1016/j.amjmed.2018.03.031.
Silver SA, Chertow GM. The economic consequences of acute kidney injury. Nephron. 2017;137:297–301. https://doi.org/10.1159/000475607.
Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014. BMC Health Serv Res. 2018;18:715. https://doi.org/10.1186/s12913-018-3529-4.
Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9:196–203. https://doi.org/10.3201/eid0902.020232.
Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, et al. multimodal patient blood management program based on a three-pillar strategy. Ann Surg. 2019;269:794–804. https://doi.org/10.1097/SLA.0000000000003095.
Vaglio S, Prisco D, Biancofiore G, Rafanelli D, Antonioli P, Lisanti M, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus. 2016;14:23–65. https://doi.org/10.2450/2015.0172-15.
Gómez-Ramírez S, Bisbe E, Shander A, Spahn DR, Muñoz M. management of perioperative iron deficiency anemia. Acta Haematol. 2019;142:21–9. https://doi.org/10.1159/000496965.
Ethics approval and consent to participate
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hamaway, S., Hadid, B., Vakharia, R.M. et al. The association of iron deficiency anemia and perioperative complications following revision total knee arthroplasty. Arthroplasty 4, 34 (2022). https://doi.org/10.1186/s42836-022-00129-4